XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Summary of Estimated Fair Value of Stock Option Award The estimated fair value of each stock option award granted was determined on the date of grant using the Black-Scholes option-pricing valuation model with the following assumptions for option grants during the three and six months ended June 30, 2022 and 2021:

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Common Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk free interest rate

 

2.82% - 3.55%

 

 

0.91% - 1.08%

 

 

1.67% - 3.55%

 

 

0.57% - 1.08%

 

Expected option term

 

5.5 - 6.0 years

 

 

5.5 - 6.0 years

 

 

5.5 - 6.0 years

 

 

5.5 - 6.0 years

 

Expected volatility of common stock

 

97.04% - 113.23%

 

 

105.93%-107.53%

 

 

97.04% - 113.23%

 

 

103.45%-107.53%

 

Expected dividend yield

 

0.0%

 

 

0.0%

 

 

0.0%

 

 

0.0%

 

 

Summary of Estimated Fair Value of Shares to be Acquired under Employee Stock Purchase Plan

The estimated fair value of the shares to be acquired under the ESPP was determined on the initiation date of each six-month purchase period using the Black-Scholes option-pricing valuation model with the following assumptions for ESPP shares to be purchased during the three and six months ended June 30, 2022 and 2021:

 

 

 

Three and Six Months Ended

June 30, 2022

 

 

Three and Six Months Ended

June 30, 2021

 

Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

Risk free interest rate

 

 

 

 

0.13%

 

Expected term

 

 

 

 

0.5 years

 

Expected volatility of common stock

 

 

 

 

111.98%

 

Expected dividend yield

 

 

 

 

0.0%

 

Summary of Recognized Stock-Based Compensation Expense

There were no employee withholdings to purchase shares during the six-month purchase period beginning September 1, 2021 and March 1, 2022.

The Company recognized stock-based compensation expense to employees and directors in its research and development and its selling, general and administrative functions during the three and six months ended June 30, 2022 and 2021 as follows:

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

3,752

 

 

$

23,820

 

 

$

5,608

 

 

$

92,200

 

Selling, general and administrative

 

 

363,172

 

 

 

375,591

 

 

 

742,377

 

 

 

868,559

 

Total stock-based compensation expense

 

$

366,924

 

 

$

399,411

 

 

$

747,985

 

 

$

960,759